Clinical white paper
Design thinking to establish clinical use case and business case
Tailor-made algorithm specifications
REMOTE MONITORING
In-License
In-Licensing from collaborative research (commercialisation rights)
HOP direct case and in-kind investments
Syndicate with private investments & discovery grants
Out-License
Out-license (algorithms)
OEM (private label) to pharmas and DTx companies
Facilitate regulatory compliance procedures
